| PD-1/PD-L1 | programmed cell death protein 1/programmed cell death ligand 1 |
| CAR-T cell | chimeric antigen receptor T-cell |
| DCs | dendritic cells |
| ILCs | innate lymphocytes |
| NK | natural killer |
| PRRs | pattern recognition receptors |
| PAMPs | pathogen-associated molecular patterns |
| DAMPs | danger-associated molecular patterns |
| cGAS | cyclic guanosine monophosphate-adenosine monophosphate synthase |
| dsDNA | double-stranded DNA |
| STING | stimulator interferon gene |
| ER | endoplasmic reticulum |
| cGAMP | cyclic guanosine monophosphate-adenosine monophosphate |
| IFN | interferon |
| APCs | antigen-presenting cells |
| STAT1 | signal transducer and activator of transcription 1 |
| EMT | epithelial-mesenchymal transition |
| TME | tumor microenvironment |
| ISG | invariant surface glycoprotein |
| cGAMP-NP | cGAMP nanoparticles |
| MDSCs | myeloid derived suppressor cells |
| IDO | indolamine 2,3-dioxygenase |
| LKB1 | liver kinase B1 |
| NSCLC | non-small cell lung cancer |
| CMA | chaperone-mediated autophagy |
| ATG | autophagy-related gene |
| PI3K | phosphoinositide 3-kinase |
| PE | phosphatidylethanolamine |
| PI3KC3 | class III PI3K |
| ROS | reactive oxygen species |
| FoxO | Forkhead box O |
| UBD | ubiquitin binding domain |
| MHC | major histocompatibility complex |
| PDAC | pancreatic ductal adenocarcinoma |
| LAP | LC3-associated phagocytosis |
| TAMs | tumor-associated macrophages |
| Gal-1 | galectin-1 |
| HCC | Hepatocellular carcinoma |
| LIRs | LC3-interacting regions |
| TRIM14 | triplet motif containing 14 |
| ERGIC | ER–Golgi intermediate compartment |
| UPR | unfolded protein response |
| PERK | PKR-like ER kinase |
| TGN | trans-Golgi network |